Add a listing
    Add a listing

    BioAge Labs

      We are developing a broad pipeline of therapies to extend human healthspan and lifespan.

    General
    • Headquarters

      Richmond, California, United States

    • Founders & Team

      Kristen Fotrney, Eric Morgen

    • Year Founded

      2015

    • Company type

      Private company

    • Funding stage

      Series B

    • Total funding ($M)

      33.9

    • Investors

      Felicis Ventures, Khosola Ventures, Andreesen Horowitz, Pear VC, Elad Gil,

    Technical Details
    • Aging Target

      De-regulated nutrient sensing, Immunosenescence

    • Clinical stage

      Pre-clinical

    • Product names

      BGE-117

    About

    BIOAGE develops drugs to treat aging and its associated diseases. We are backed by Andreessen Horowitz, AME Cloud Ventures, PEAR Ventures, Felicis Ventures, Caffeinated Capital, and others. We have created a unique computational platform that leverages proprietary omics data from large human cohorts to identify the molecular pathways that influence longevity. We then develop drugs that target these pathways and treat specific age-related diseases.

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In